| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $601.8M | +38.0% |
| Cost of Revenue | $394.6M | +23.3% |
| Gross Profit | $207.2M | +78.4% |
| R&D Expense | $270.7M | +55.2% |
| SG&A Expense | $165.3M | +25.7% |
| Operating Income | -$228.8M | -20.6% |
| Pre-tax Income | -$225.9M | -19.3% |
| Income Tax | -$27.7M | -3724.1% |
| Net Income | -$198.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $828.7M | +205.7% |
| Short-term Investments | $187.9M | +27.0% |
| Accounts Receivable | $39.0M | +7.0% |
| Inventory | $158.4M | +33.0% |
| Current Assets | $1.37B | +97.2% |
| Total Assets | $2.32B | +96.3% |
| Current Liabilities | $334.5M | -1.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$165.5M | -238.6% |
| Capital Expenditures | $156.3M | +132.9% |
| Investing Cash Flow | -$347.4M | -253.3% |
| Financing Cash Flow | $1.07B | +317.4% |
| Free Cash Flow | -$321.8M | -177.5% |
| -4.2% |
| EPS (Basic) | -$0.37 | +2.6% |
| EPS (Diluted) | -$0.37 | +2.6% |
| Long-term Debt |
| $152.4M |
| -55.9% |
| Total Liabilities | $602.6M | -24.8% |
| Stockholders' Equity | $1.72B | +350.2% |